Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis

Oncogene

Volumn 30, Issue 25, 2011, Pages 2836-2845

  Meng, L ^a   Hunt, C ^b   Yaglom, J A ^a   Gabai, V L ^a   Sherman, M Y ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HER2; Hsp72; p21; senescence; survivin

Indexed keywords

HEAT SHOCK PROTEIN 72; PROTEIN P21; SURVIVIN;

ARTICLE; BREAST CANCER; BREAST TUMOR; CARCINOGENESIS; CELL AGING; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN FUNCTION; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; HSP72 HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; RECEPTOR, ERBB-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MUS;

EID: 79959670292     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.5     Document Type: Article

References (28)

1. Altieri DC. (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22: 8581-8589.
2. Altieri DC. (2008). Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61-70.
3. Akerfelt M, Morimoto RI, Sistonen L. (2010). Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol 11: 545-555.
4. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. (2006). Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31: 164-172.
5. Ciocca DR, Calderwood SK. (2005). Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86-103.
6. Dai C, Whitesell L, Rogers AB, Lindquist S. (2007). Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130: 1005-1018.
7. Gabai VL, Budagova KR, Sherman MY. (2005). Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene 24: 3328-3338.
8. Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI et al. (1997). Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem 272: 18033-18037.
9. Gabai VL, Yaglom JA, Waldman T, Sherman MY. (2009). Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol Cell Biol 29: 559-569.
10. Hunt CR, Dix DJ, Sharma GG, Pandita RK, Gupta A, Funk M et al. (2004). Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice. Mol Cell Biol 24: 899-911.
11. Jaattela M. (1999). Escaping cell death: survival proteins in cancer. Exp Cell Res 248: 30-43.
12. Jolly C, Morimoto RI. (2000). Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92: 1564-1572.
13. Leu JI, Pimkina J, Frank A, Murphy ME, George DL. (2009). A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 36: 15-27.
14. Lindquist S, Craig EA. (1988). The heat-shock proteins. Annu Rev Genet 22: 631-677.
15. Luo J, Solimini NL, Elledge SJ. (2009). Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136: 823-837.
16. Meng L, Gabai VL, Sherman MY. (2010). Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene 29: 5204-5213.
17. Min JN, Huang L, Zimonjic DB, Moskophidis D, Mivechi NF. (2007). Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 26: 5086-5097.
18. Mooi WJ, Peeper DS. (2006). Oncogene-induced cell senescence- halting on the road to cancer. N Engl J Med 355: 1037-1046.
19. Mosser DD, Morimoto RI. (2004). Molecular chaperones and the stress of oncogenesis. Oncogene 23: 2907-2918.
20. Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, Cardiff RD et al. (1996). Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol Cell Biol 16: 5726-5736.
21. Powers MV, Clarke PA, Workman P. (2008). Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 14: 250-262.
22. Sherr CJ. (2004). Principles of tumor suppression. Cell 116: 235-246.
23. Solimini NL, Luo J, Elledge SJ. (2007). Non-oncogene addiction and the stress phenotype of cancer cells. Cell 130: 986-988.
24. Tang D, Kang R, Xiao W, Wang H, Calderwood SK, Xiao X. (2007). The anti-inflammatory effects of heat shock protein 72 involve inhibition of high-mobility-group box 1 release and proinflammatory function in macrophages. J Immunol 179: 1236-1244.
25. Tao Y, Hart J, Lichtenstein L, Joseph LJ, Ciancio MJ, Hu S et al. (2009). Inducible heat shock protein 70 prevents multifocal flat dysplastic lesions and invasive tumors in an inflammatory model of colon cancer. Carcinogenesis 30: 175-182.
26. Trost TM, Lausch EU, Fees SA, Schmitt S, Enklaar T, Reutzel D et al. (2005). Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells. Cancer Res 65: 840-849.
27. Yaglom JA, Gabai VL, Sherman MY. (2007). High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res 67: 2373-2381.
28. Zaarur N, Gabai VL, Porco Jr JA, Calderwood S, Sherman MY. (2006). Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res 66: 1783-1791.